𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutation screening of the CDKN2A promoter in melanoma families

✍ Scribed by Mark Harland; Elizabeth A. Holland; Paola Ghiorzo; Michela Mantelli; Giovanna Bianchi-Scarrà; Alisa M. Goldstein; Margaret A. Tucker; Bruce A.J. Ponder; Graham J. Mann; D. Timothy Bishop; Julia Newton Bishop

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
162 KB
Volume
28
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis

Germline mutations of CDKN2A, at 9p21, are responsible for predisposition to melanoma in some families. However, evidence of linkage to 9p21 has been demonstrated in a significant proportion of kindreds with no detectable mutations in CDKN2A. It is possible that mutations in noncoding regions may be responsible for predisposition to melanoma in these families. We have analyzed approximately 1 kb of the CDKN2A promoter upstream of the start codon in an attempt to identify causal mutations in 107 melanoma families. Four sequence variants were detected. Two of these (A-191G and A-493T) did not segregate with disease and were present in a control population at a comparable frequency, indicating that they are unlikely to predispose to melanoma. The A-493T variant appeared to be in linkage disequilibrium with the previously described CDKN2A polymorphism Ala148Thr. The variant G-735A was detected in the control population, but segregation of this variant with melanoma within families could not be discounted. The fourth variant (G-34T), located in the 5Ј UTR, creates an aberrant initiation codon. This variant appeared to segregate with melanoma and was not detected in a control population. G-34T has recently been identified in a subset of Canadian melanoma families and was concluded to be associated with predisposition to melanoma. The creation of an aberrant initiation site in the 5Ј UTR may have an important role in carcinogenesis in a small percentage of families; however, mutations in the CDKN2A promoter appear to have a limited role in predisposition to melanoma.

📜 SIMILAR VOLUMES

Screening of germline mutations in the C
Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic-based population study
✍ Anton Platz; Johan Hansson; Ulrik Ringborg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 61 KB 👁 2 views

Germline mutations within the CDKN2A gene, coding for the cyclin-dependent kinase inhibitor p16, have been detected by screening in 8% of Swedish families with an inheritance of cutaneous melanoma (FMM) and dysplastic nevus syndrome (DNS). Contrastingly, the closely related gene CDKN2B had no diseas

Haplotype analysis of two recurrent CDKN
Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: Evidence for common founders and independent mutations
✍ Pamela M. Pollock; Nigel Spurr; Tim Bishop; Julia Newton-Bishop; Nelleke Gruis; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

Germ-line mutations in CDKN2A have been shown to predispose to cutaneous malignant melanoma. We have identified 2 new melanoma kindreds which carry a duplication of a 24bp repeat present in the 5' region of CDKN2A previously identified in melanoma families from Australia and the United States. This

CDKN2A (P16INK4a) and CDK4 mutation anal
CDKN2A (P16INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas
✍ Elizabeth A. Holland; Helen Schmid; Richard F. Kefford; Graham J. Mann 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 1 views

Mutation analysis of two genes involved in melanoma susceptibility (CDKN2A/p16 INK4a and CDK4) was undertaken in 131 probands with a family history of melanoma. Screening of all three exons of CDKN2A and exon 2 of CDK4 by single-strand conformation polymorphism (SSCP) analysis and/or direct sequenci

Affected members of melanoma-prone famil
Affected members of melanoma-prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19ARF
✍ Ling Liu; Alisa M. Goldstein; Margaret A. Tucker; Herbert Brill; Nelleke A. Grui 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Mutations in the gene encoding the cell cycle inhibitor CDKN2A have been identified in some melanoma kindreds linked to 9p21. However, many such families show no evidence of mutations in the coding regions of CDKN2A. In this study, we examined whether two other potential tumor suppressors, CDKN2B an